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Abstract
Objective
The endothelium is a key mediator of vascular homeostasis and cardiovascular health. Mo-
lecular research on the human endothelium may provide insight into the mechanisms un-
derlying cardiovascular disease. Prior methodology used to isolate human endothelial cells
has suffered from poor yields and contamination with other cell types. We thus sought to de-
velop a minimally invasive technique to obtain endothelial cells derived from human sub-
jects with higher yields and purity.
Methods
Nine healthy volunteers underwent endothelial cell harvesting from antecubital veins using
guidewires. Fluorescence-activated cell sorting (FACS) was subsequently used to purify en-
dothelial cells from contaminating cells using endothelial surface markers (CD34 / CD105 /
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CD146) with the concomitant absence of leukocyte and platelet specific markers (CD11b /
CD45). Endothelial lineage in the purified cell population was confirmed by expression of en-
dothelial specific genes and microRNA using quantitative polymerase chain reaction (PCR).
Results
Amedian of 4,212 (IQR: 2161 – 6583) endothelial cells were isolated from each subject.
Quantitative PCR demonstrated higher expression of von Willebrand Factor (vWF,
P<0.001), nitric oxide synthase 3 (NOS3, P<0.001) and vascular cell adhesion molecule 1
(VCAM-1, P<0.003) in the endothelial population compared to similarly isolated leukocytes.
Similarly, the level of endothelial specific microRNA-126 was higher in the purified endothe-
lial cells (P<0.001).
Conclusion
This state-of-the-art technique isolates human endothelial cells for molecular analysis in
higher purity and greater numbers than previously possible. This approach will expedite re-
search on the molecular mechanisms of human cardiovascular disease, elucidating its
pathophysiology and potential therapeutic targets.
Introduction
The human endothelium is a key mediator of vascular homeostasis and overall cardiovascular
health [1]. Endothelial dysfunction thus confers an adverse cardiovascular prognosis and plays
a central role in the development of atherosclerosis and its clinical complications [2]. Sampling
human endothelial cells from living subjects would potentially allow investigators to character-
ize the biology of the endothelium on a molecular level in both health and disease. Further, re-
search focused on endothelial cells derived from human subjects could elucidate the molecular
underpinnings of endothelial dysfunction while helping to identify novel biomarkers and po-
tential therapeutic targets to mitigate the clinical manifestations of atherosclerosis [2].
Prior studies have described a method to isolate human endothelial cells from iliac arteries
in patients undergoing angiography [3]. This methodology yielded an average of 262 endotheli-
al cells and employed immunocytochemistry as well as single cell reverse transcription poly-
merase chain reaction (PCR) to analyze proteins and transcripts expressed at the site of
vascular lesions. This minimally invasive procedure has yielded important insights into the
role of the endothelium in various diseases, including heart failure and diabetes [4–6]. The
technique has been limited, however, by low cellular yields and contamination of endothelial
cells with other circulating cell types [4,7]. A standardized method to consistently produce a
homogeneous population of human endothelial cells suitable for molecular studies would thus
have significant utility. Accordingly, we report a novel technique to isolate human endothelial
cells with a marked increase in yield and purity.
Methods
Population
The present study included healthy volunteers enrolled in a study involving smoke exposure at
San Francisco General Hospital. Briefly, this cohort consisted of non-smoking healthy volunteers
that were recruited to evaluate the cardiovascular effects of second-hand and third-hand cigarette
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smoke exposure. Each individual underwent endothelial cell sampling before and after exposure
to smoke or clean air using a randomized, cross-over experimental design. All subjects provided
written informed consent for this portion of the investigation and the study was approved by the
Committee on Human Research at the University of California, San Francisco. Furthermore, this
study was conducted under the guidelines specified in the Declaration of Helsinki.
Endothelial Cell Sampling
Nine human volunteers underwent simultaneous peripheral blood and endothelial cell sam-
pling from the antecubital vein. A 21-gauge peripheral intravenous catheter was placed in the
antecubital vein under semi-sterile conditions using standard technique. Four 0.025” J-wires
measuring 35 cm in length and constructed of stainless steel (Arrow International, Teleflex In-
corporated, Research Triangle Park, NC) were sequentially inserted into the previously placed
peripheral intravenous cannula. Each wire was advanced into the vessel and then withdrawn
ten times while external compression was applied to the vein to increase contact between the
wire and vessel wall. The wires were then inserted into a conical tube containing commercially
available Cell Dissociation Buffer (Gibco, Life Technologies, Waltham, MA). The entire har-
vesting procedure was consistently completed within five minutes or less.
Fluorescence-Activated Cell Sorting
Purification of the isolated cellular population was performed immediately after cell sampling.
Cells adherent to the J-wires were removed via mechanical dissociation with a vortex at medi-
um speed for 10 seconds. The resulting solution was subsequently centrifuged and the pellet
was resuspended in phosphate buffered saline with 0.5% bovine serum albumin (BSA) and
2 mM ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich, St. Louis, MO). The solution
was then incubated with fluorescently-conjugated monoclonal antibodies to distinguish endo-
thelial cells (CD45 - / CD11b- / CD42lo / CD31+ / CD34 + / CD105+ / CD146 +) from leuko-
cytes (CD45+) and platelets (CD45- / CD42bhi) (Table 1) [8–13]. Following incubation,
additional buffer was added and the sample was again centrifuged. The resulting cellular pellet
was resuspended in 1 ml ammonium-chloride-potassium red cell lysis solution (Sigma-Al-
drich) for five minutes at room temperature. After incubation, the cellular pellet was resus-
pended in 1 ml of buffer. Samples were subsequently sorted on a Becton-Dickinson FACS-Aria
II according to the gating strategy illustrated in Fig. 1 to obtain endothelial cells and leukocytes.
Controls included single stained beads (Life Technologies, Woburn, MA) for software-based
compensation as well as whole venous blood processed and stained in parallel to assist with set-
ting the anchor gates for each sort. The venous blood samples also served as a negative control,
given the low number of isolated endothelial cells (Fig. 1, Row A). In addition, fluorescence-
minus-one (FMO) controls were prepared on a subset of samples to demonstrate that staining
Table 1. Antigens and antibodies utilized for purification of human endothelial cells.
Antigen Name Clone Fluorophore Vendor
CD11b Integrin Alpha M ICRF44 BV-421 BioLegend
CD31 PECAM-1 WM59 Alexa-647 BD Biosciences
CD34 Glycoprotein for Cell Adhesion 581 PE-Cy7 BioLegend
CD42b Glycoprotein 1b HIP1 FITC BD Biosciences
CD45 Protein Tyrosine Phosphatase HI30 Alexa-700 Invitrogen
CD105 Endoglin, TGF Beta Receptor 266 PE-CF594 BD Biosciences
CD146 Melanoma Cell Adhesion Molecule P1H12 PE BD Biosciences
doi:10.1371/journal.pone.0118081.t001
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with endothelial markers represented true antigen staining while also helping determine the
proper location of the sorting gates to collect endothelial cells (Fig. 1, Row C). Cells were sorted
into RNAse free tubes, pelleted immediately after sorting and then re-suspended in CellsDirect
resuspension buffer with RNAse inhibitor (Life Technologies) before being store at -80°C until
further analysis.
RNA Extraction and Preparation
Gene expression was performed in the isolated endothelial cells and a leukocyte fraction
(CD45+) isolated in parallel from the retrieved guidewires. As previously described, the num-
ber of freeze-thaw cycles was kept to a minimum in order to prevent degradation of mRNA
and microRNA (miRNA) [14]. Total RNA extraction was performed using a MicroRNA Ex-
traction Kit (Benevbio) according to the instructions supplied by the manufacturer. Reverse
transcription was then performed to generate cDNA representing levels of either mRNA (High
Fidelity cDNA Amplification Kit, Thermo Fisher Scientific/Life Technologies) or mature
Fig 1. Fluorescence-activated cell sorting (FACS) Gating Strategy. The gating strategy to first eliminate leukocytes and platelets is shown on a
representative endothelial biopsy sample (B) and a matched venous blood sample (A). Single cells are identified by plotting forward scatter-area against
forward scatter-height (plot I); single cells are then separated from debris by a forward versus side scatter (plot II); leucocytes are eliminated by gating on
CD45-negative (plot III) and CD11b-negative (plot IV) events; then platelets are eliminated by gating on CD42b-negative events (plot V). The brightly stained
CD31+CD42b- events (plot V) shown in the endothelial biopsy sample (B) are absent from blood (A) indicating enrichment for CD31+ endothelial cells. Row
C shows further enrichment of the CD31+ cells from an endothelial biopsy (All Stain) by positive selection with the endothelial markers, CD34 (plot VI),
followed by CD146 and CD105 (plot VII). Endothelial biopsy samples were also stained with FMO controls for CD34 (plot VI), CD146 (plot VII) and CD105
(plot VII) to help set gates for sorting of the All Stain sample. Endothelial cells CD45-CD11b-CD42b-CD31+CD34+CD146+CD106+ (row C plot VII) and
CD45+ lymphocytes (row B plot III) were sorted from endothelial biopsy samples.
doi:10.1371/journal.pone.0118081.g001
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miRNAmolecules (MicroRNA Assay Kit, Thermo Fisher Scientific/Life Technologies) [15].
Given the stem loop structures of the miRNA primers used for the initial reverse transcription,
only mature miRNA molecules were amplified into cDNA. The reliability of the mRNA and
miRNA extraction data was tested by quantifying the expression levels of the housekeeping
gene β-actin [AB 4331182 (Hs99999903_m1)] and the small RNA, RNU48 [AB 4427975
(001006)] using specific RNA primers for amplification [16–18]. To allow detection of messen-
ger transcript derived from a small number of cells, pre-amplification of cDNA representing
levels of mRNA was performed (Taqman PreAmp Master Mix Kit, Thermo Fisher Scientific/
Life Technologies) per the instructions supplied by the manufacturer.
Quantification of mRNA and miRNA
After pre-amplification, Real Time Quantitative PCR (RT-QPCR) was utilized according to the
two-step method for quantifying the levels of the candidate mRNA and miRNA in each sam-
ple. In the first step to generate cDNA constructs representing endogenous mRNA transcripts,
random hexamers were used to conduct first-strand cDNA synthesis reactions for genes
known to be differentially expressed in endothelial cells and leukocytes: von Willebrand Factor
(vWF) [AB 4331182 (Hs01109446_m1)], nitric oxide synthase 3 (NOS3) [AB 4331182
(Hs01574659_m1)], vascular cell adhesion molecule 1 (VCAM-1) [AB 4331182
(Hs00365485_m1)] and CD45 [AB 4331182 (Hs04189704_m1)]. Then, an Applied Biosystems
7900HT Fast Real Time PCR device was used to amplify cDNA using a fluorescently labeled
Taqman probe and primer set (Thermo Fisher Scientific/Life Technologies). Similarly, for
quantifying the expression of an endothelial-enriched microRNA, microRNA-126 [19], we
used a miR-126-specific stem loop-based RT primer for amplification as a first cDNA synthesis
step. Subsequently, an Applied Biosystems 7900HT Fast Real Time PCR device was used to
amplify such cDNA using a fluorescently labeled Taqman probe and primer set specific for
miR-126 [AB 4427975 (002228)] (Thermo Fisher Scientific/Life Technologies). Raw Ct values
were measured which represent the “real-time” cycle count at which the Taqman probe fluo-
rescence increases exponentially. Relative expression (or fold-change) was calculated using the
formula 2(–ΔΔCt), as described previously [16]. The reliability of mRNA and miRNA extraction
was supported by additional measurement of the housekeeping gene β-actin, which was used
as the reference control for mRNA quantification, and the small RNA RNU48, which was used
as the reference control for miRNA quantification. Amplicon sequences for each RT-QPCR re-
action are listed in Table 2.
Statistical Analysis
All data is presented as medians (intraquartile ranges, IQR) for non-normally distributed data
and frequency (percentage) for categorical data. Gene expression data are presented as bar
graphs representing the mean fold change compared to a reference with error bars representing
the standard error of the mean (SEM). Comparison of mRNA and miRNA values were made
between the endothelial sample and leukocyte sample fraction via a two-tailed, non-paired t-
test. A p-value< 0.05 was considered statistically significant.
Results
The median age of the nine healthy subjects studied was 46 years (IQR: 34–49) and 67% were
male. Each of the subjects tolerated the endothelial cell sampling procedure well without
any complications.
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Cell Sorting
The multi-parametric gating scheme effectively isolated endothelial cells from the other cell
populations found in peripheral blood (Fig. 1). Compared to leukocytes and platelets, endothe-
lial cells were larger and more granular based on forward and side-scatter profiles. Leukocytes
and platelets were first excluded based on expression of CD45, CD11b and CD42b while endo-
thelial cells were then identified based on expression of endothelial cell surfaces markers CD31,
CD34, CD105 and CD146. The median cellular yield using this seven surface marker specific
isolation method was 4,212 (IQR: 2161–6583) cells per subject.
Gene Expression
Gene expression profiling of the isolated cell fractions demonstrated an endothelial rich popu-
lation, when compared to leukocytes isolated from guidewires from the same subjects in paral-
lel (Fig. 2). Quantitative PCR demonstrated significantly increased expression of vWF
(P<0.001), NOS3, (P<0.001) and VCAM-1 (P<0.003) in the purified endothelial population
without expression of CD45 characteristic of leukocytes, though this did not reach statistical
significance likely due to the small sample size (P = 0.101,D). In addition to these traditional
mRNA endothelial markers, we also demonstrated enrichment of the endothelial cell-specific
miRNA-126 in the isolated endothelial fraction as compared to the leukocyte fractions
(P<0.001) (Fig. 3).
Discussion
The present study describes a novel minimally-invasive technique to harvest and purify large
quantities of homogeneous human endothelial cells suitable for molecular analysis. As the data
demonstrate, this optimized approach results in endothelial cell yields that are twenty-fold
greater than previously reported and with favorable purity, enabling analysis of gene expression
and gene regulation. Future investigations employing this technique could elucidate the unique
molecular mechanism underlying endothelial dysfunction in a variety of cardiovascular disease
Table 2. Amplicon sequences for primers analyzing endothelial cell-specific gene expression and
mature microRNA sequences for primers analyzing microRNA expression.
Gene Amplicon/Mature Sequence
CD45 (PTPRC) 5’-GTGACAGGGCAAAGCCCAACACCTTCCCCCACTGGCCATCTGCAAGC-
TGAGGAGCAA-3’
Nitric Oxide
Synthase 3 (NOS3)
5’- AGCAGGATGGGCCCTGCACCCCAAGACGCTGCCTGGGCTCCCTGGTATTT-
CCACGGAAACTACAGGGCCGGCCCTCCCCCGGCCCCCCGGCCCCTGAGCAG-
CTGCTG-3’
Vascular Cell
Adhesion Molecule
1 (VCAM-1)
5’- CCAGAGATACAACCGTCTTGGTCAGCCCTTCCTCCATCCTGGAGG-
AAGGCAGTTCTGTGAAT-3’
von Willebrand
Factor (vWF)
5’- ACCCTTTGTGCAGAAGGAACTCGCGGCAGGTCATCCACGGCCCGATGCA-
GCCTTTT-3’
miR-126 5’- UCGUACCGUGAGUAAUAAUGCG-3
β-Actin (ACTB) 5’-GGCGTGATGGTGGGCATGGGTCAGAAGGATTCCTATGTGGGCGACGAGG-
CCCAGAGCAAGAGA-3’
RNU48 5’- GATGACCCCAGGTAACTCTGAGTGTGTCGCTGATGCCATCACCGCAGCGC-
TCTGACC-3’
doi:10.1371/journal.pone.0118081.t002
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states thus leading to development of biomarkers and potentially the identification of novel
therapeutic targets.
Fifteen years ago, Feng et al first described a technique for isolating human endothelial cells
from iliac arteries [3]. Since this initial report, this methodology has been widely employed but
often limited by low numbers of endothelial cells, contaminated with peripheral blood cells. In
Fig 2. Endothelial cell molecular profiling (mRNA). Expression of endothelial specific genes such as (A) vonWillebrand Factor (vWF), (B) nitric oxide
synthase 3 (NOS3) and (C) vascular adhesion molecule 1 (VCAM-1) are significantly greater in the endothelial cell fraction compared to the leukocyte
fraction. In contrast, expression of a leukocyte marker (CD45) (D) was numerically greater in the leukocyte cell fraction when compared to the endothelial
faction (P = 0.101). Messenger RNA expression levels are referenced to β–actin. All values are mean fold change with the bars representing the standard
error. ** Indicates P<0.001. *** Indicates P<0.003.
doi:10.1371/journal.pone.0118081.g002
Molecular Profiling of Human Endothelial Cells
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the present study, we report a revised technique to harvest human endothelial cells from an
antecubital vein, a simple procedure that carries no additional risk above placing a peripheral
intravenous catheter and can be easily performed in the outpatient setting or incorporated into
any more invasive endovascular procedure. Subsequent isolation and purification with multi-
parameter FACS using endothelial specific markers leads to a sufficient quantity of endothelial
cells which allow for analysis of gene, protein and metabolite expression, studies which all re-
quire a high level of cellular homogeneity [20]. This technique also removes contaminating
cells, such as leukocytes or platelets, that may interact with the endothelial cells of interest and
alter their measured expression profiles ex vivo [21].
The wide application of this easily performed and highly adaptable technique could lead to
a better understanding of endothelial cell physiology and pathophysiology. Previous research
has suggested that gene expression in venous endothelial cells correlates well with expression
in arterial endothelial cells, reinforcing the systemic nature of endothelial dysfunction [22]. Ve-
nous sampling as opposed to arterial sampling has thus become standard [4,23]. Endothelial
cell sampling could now be performed when a peripheral intravenous line is placed in the out-
patient or inpatient setting to garner a better understanding of systemic endothelial health. The
technique is flexible enough, however, to also be performed in the arterial circulation when ac-
cess is obtained for endovascular procedures, such as peripheral or coronary angiography. Si-
multaneous sampling of the arterial and venous endothelium in such a patient could advance
our understanding of the similarities and differences in endothelial gene expression throughout
the vasculature, furthering the investigation of human endothelial cell heterogeneity. The puri-
fication process is also easily adaptable as additional monoclonal antibodies could be included
Fig 3. Endothelial cell molecular profiling (microRNA). Expression of endothelial specific microRNA-126
was significantly greater in the endothelial cell fraction when compared to the leukocyte faction. MicroRNA
expression levels are referenced to RNU48. All values are mean fold change with the bars representing the
standard error. ** Indicates P<0.001.
doi:10.1371/journal.pone.0118081.g003
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to identify surface antigens of interest. Cellular fixation and permeabilization steps could be
added to the protocol to identify intracellular antigens, such as NF- κB, or post-translational
protein modifications such as phosphorylation of eNOS. Alternatively, the cellular subpopula-
tion could be subsequently used for quantitative analysis of any mRNA or miRNA of interest.
Through this approach, one could gain a better appreciation of endothelial function and its
contribution to human disease.
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